Loading
Yanuki
SUBCATEGORY FEED
Legal Questions Swirl Around FDA’s New Expedited Drug Program | UnitedHealth Group Imploding Amidst Fraud Investigation | Legal Questions Swirl Around FDA’s New Expedited Drug Program | UnitedHealth Group Imploding Amidst Fraud Investigation

Business / Health

Legal Questions Swirl Around FDA’s New Expedited Drug Program

The FDA’s expedited drug review program, championed by the previous administration, faces scrutiny over legal and ethical concerns. This initiative, designed to fast-track the approval of certain medications, has raised questions about the...

Legal Questions Swirl Around FDA’s New Expedited Drug Program Image via Reuters
Some drugmakers quietly concerned about legal risk with speedy FDA review program
Retail Finance Economy Media Energy Trade Legal Markets Automotive International Trade